Enjuvia Approval History
- FDA approved: Yes (First approved May 10th, 2004)
- Brand name: Enjuvia
- Generic name: synthetic conjugated estrogens, B
- Dosage form: Tablets
- Company: Duramed Pharmaceuticals
- Treatment for: Postmenopausal Symptoms, Atrophic Vaginitis
Enjuvia (synthetic conjugated estrogens, B) is a synthetic conjugated estrogen product indicated for the treatment of menopausal vasomotor symptoms and for the treatment of vaginal dryness and atrophy.
Development History and FDA Approval Process for Enjuvia
|Apr 30, 2007||Duramed's Enjuvia (Synthetic Conjugated Estrogens, B) TabletsReceives Two New FDA Approvals|
|May 10, 2004||Enjuvia Duramed Pharmaceuticals - Treatment for Menopausal Vasomotor Symptoms|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.